The updated ASCO/CAP guideline recommendations for HER2 testing in the management of invasive breast cancer: a critical review of their implications for routine practice-Reference-Cited by-同舟云学术

The updated ASCO/CAP guideline recommendations for HER2 testing in the management of invasive breast cancer: a critical review of their implications for routine practice

Published:2014-01-31 Issue:5 Volume:64 Page:609-615
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Rakha Emad A¹,Starczynski Jane²,Lee Andrew H S¹,Ellis Ian O¹

Affiliation:

1. Division of Oncology; School of Medicine; University of Nottingham; Nottingham City Hospital; Nottingham UK

2. Department of Cellular Pathology; Birmingham Heartlands Hospital; Birmingham UK

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.12357/fullpdf

Reference24 articles.

1. HER2 status and benefit from adjuvant trastuzumab in breast cancer;Paik;N. Engl. J. Med.,2008

2. Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31;Perez;J. Clin. Oncol.,2011

3. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N. Engl. J. Med.,2005

4. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer;Wolff;J. Clin. Oncol.,2007

5. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;J. Clin. Oncol.,2013

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Her-2/neu value in papillary thyroid carcinoma and its relation to histopathological prognostic findings;Cancer Treatment and Research Communications;2024

2. HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method;Virchows Archiv;2023-11-23

3. HER2 status based on breast cancer guidelines as a useful prognostic marker of T2 gallbladder cancer;European Journal of Surgical Oncology;2023-02

4. A novel binary luminophore based high-efficient electrochemiluminescence biosensor for ultrasensitive detection of human epidermal growth factor receptor-2;Chemical Engineering Journal;2022-12

5. Naples prognostic score: a novel predictor of survival in patients with HER2-positive breast cancer;Future Oncology;2022-07